Korro Bio, Inc. Other Current Liabilities
Korro Bio, Inc. (KRRO) had Other Current Liabilities of $296.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2022-11-08
- 2022-09-30: Other Liabilities, Current $296.00K.
- 2021-12-31: Other Liabilities, Current $0.00.
- 2019-12-31: Other Liabilities, Current $170.00K.
- 2019-09-30: Other Liabilities, Current $168.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2022-09-30 | $296.00K 10-Q · filed 2022-11-08 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-08 |
| 2019-12-31 | $170.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $168.00K 10-Q · filed 2019-11-18 |
| 2018-12-31 | $161.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |